Delivery Order SPE2DB22D3301-SPE2DB25FY9DN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Injectafer 750 mg/15 ml vials. This is a firm fixed price delivery order with a ceiling value of $27,463.25 and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and was awarded without a set-aside designation, indicating competitive procurement. This...
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $19,186.58 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on September 8, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The contract involves no set-aside designation, indicating open competition among...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,270.54 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. The contract, which is not set-aside, was competitively awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The product will be delivered to Conshohocken, Pennsylvania, utilizing a firm fixed price arrangement. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,003.41 firm fixed-price delivery order on August 5, 2025, for the supply of Injectafer 750 mg/15 mL vials. The contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $14,143.49 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Injectafer 750 mg/15 mL vials. This firm fixed-price, non-set-aside contract is scheduled for completion by June 3, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,360.20 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This non-set-aside contract, awarded on August 21, 2025, with a completion date of August 22, 2025, represents a firm fixed-price delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,075.62 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Injectafer is an intravenous iron replacement therapy used in the treatment of iron...
- The Defense Logistics Agency awarded a $21,873.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price, competitively awarded contract is scheduled for completion by August 11, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating AmerisourceBergen competed against other vendors to secure this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,765.28 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside contract utilizes firm fixed-price pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product is to be delivered to the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $13,079.20. This competitively awarded, firm fixed-price contract is classified as a child order and represents a non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order has an ultimate completion date of...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9DNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,998.79 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials. The contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and utilizes firm fixed price terms with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling value and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX prime contract vehicle enables comprehensive global pharmaceutical support to the Defense Health Agency and other federal healthcare customers through a flexible mechanism for delivering a broad range of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialized healthcare commodities. This individual delivery order for Injectafer represents a routine fulfillment within the company's larger role as a pharmaceutical prime vendor for the Department of Defense's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 8/11/25 |